What does CUSIP G50871105 represent in this 13F holders report?

CUSIP G50871105 is the security identifier for JAZZ - Jazz Pharmaceuticals plc - Common Stock used to aggregate holder disclosures.

How many institutions held JAZZ - Jazz Pharmaceuticals plc - Common Stock in Q2 2016?

354 institutional investors reported JAZZ - Jazz Pharmaceuticals plc - Common Stock for Q2 2016. Use the holders table for investor-level position and value details.

Jazz Pharmaceuticals plc - Common Stock (JAZZ)

CUSIP: G50871105

Q2 2016 13F Holders as of 30 Jun 2016

Security type / class: Equity / Common Stock
Shares outstanding: 61,577,817
Total 13F shares: 53,886,553
Share change: -365,688
Total reported value: $7,614,644,976
Put/Call ratio: 140%
Reported price per share: $141.31
Number of holders: 354
Value change: -$43,527,577
Number of buys: 195
Number of sells: 152

Security key

G50871105

Report period

Q2 2016

Institutions

354

Top holders

JAZZ full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2016 Previous quarter: Q1 2016 Jazz Pharmaceuticals plc SEC filings Jazz Pharmaceuticals plc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP G50871105

Newer quarter: Q3 2016 Previous quarter: Q1 2016

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of JAZZ - Jazz Pharmaceuticals plc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

PUTNAM INVESTMENTS LLC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2016

13F Lead comparable stake: 17% Showing first 8 of 50 holder rows. Open remaining rows

Rank 1 holder

PUTNAM INVESTMENTS LLC

13F

Ownership: 17%
Position: $1.35B

13F

Rank 2 holder

FMR LLC

13F

Ownership: 14%
Position: $1.16B

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PUTNAM INVESTMENTS LLC	13F Company 13F	17%	$1,347,721,000 10,323,406 shares	—	31 Mar 2016
FMR LLC	13F Company 13F	14%	$1,164,178,000 8,917,494 shares	—	31 Mar 2016
VANGUARD GROUP INC	13F Company 13F	6.8%	$550,114,000 4,213,817 shares	—	31 Mar 2016
WESTFIELD CAPITAL MANAGEMENT CO LP	13F Company 13F	3.3%	$266,229,000 2,039,289 shares	—	31 Mar 2016
FIL Ltd	13F Company 13F	2.9%	$234,792,000 1,798,486 shares	—	31 Mar 2016
BlackRock Fund Advisors	13F Company 13F	2.5%	$199,370,000 1,527,156 shares	—	31 Mar 2016
BlackRock Institutional Trust Company, N.A.	13F Company 13F	2.4%	$192,317,000 1,473,126 shares	—	31 Mar 2016
STATE STREET CORP	13F Company 13F	2.2%	$174,128,000 1,333,938 shares	—	31 Mar 2016

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bank of New York Mellon Corp	13F Company 13F	1.9%	$154,450,000 1,183,086 shares	—	31 Mar 2016
JANUS HENDERSON INVESTORS US LLC	13F Company 13F	1.9%	$153,332,000 1,174,477 shares	—	31 Mar 2016
JPMORGAN CHASE & CO	13F Company 13F	1.7%	$140,307,000 1,074,731 shares	—	31 Mar 2016
PFM Health Sciences, LP	13F Company 13F	1.2%	$99,790,000 764,384 shares	—	31 Mar 2016
JENNISON ASSOCIATES LLC	13F Company 13F	1.1%	$86,173,000 660,078 shares	—	31 Mar 2016
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	1%	$82,955,000 635,432 shares	—	31 Mar 2016
PRUDENTIAL FINANCIAL INC	13F Company 13F	0.99%	$79,385,000 608,077 shares	—	31 Mar 2016
BlackRock Group LTD	13F Company 13F	0.85%	$68,718,000 526,365 shares	—	31 Mar 2016
CADIAN CAPITAL MANAGEMENT, LP	13F Company 13F	0.77%	$61,912,000 474,236 shares	—	31 Mar 2016
AMUNDI ASSET MANAGEMENT US, INC.	13F Company 13F	0.75%	$60,374,000 462,460 shares	—	31 Mar 2016
CITADEL ADVISORS LLC	13F Company 13F	0.67%	$53,936,000 413,143 shares	—	31 Mar 2016
WELLS FARGO & COMPANY/MN	13F Company 13F	0.67%	$53,574,000 410,367 shares	—	31 Mar 2016
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.65%	$51,880,000 397,625 shares	—	31 Mar 2016
CLEARBRIDGE, LLC	13F Company 13F	0.62%	$49,478,000 379,000 shares	—	31 Mar 2016
NORGES BANK	13F Company 13F	0.61%	$48,661,000 372,738 shares	—	31 Mar 2016
RS INVESTMENT MANAGEMENT CO LLC	13F Company 13F	0.58%	$46,523,000 356,361 shares	—	31 Mar 2016
NORTHERN TRUST CORP	13F Company 13F	0.58%	$46,654,000 356,359 shares	—	31 Mar 2016
TIAA CREF INVESTMENT MANAGEMENT LLC	13F Company 13F	0.56%	$44,928,000 344,143 shares	—	31 Mar 2016
Invesco Ltd.	13F Company 13F	0.55%	$44,604,000 341,661 shares	—	31 Mar 2016
BLACKROCK ADVISORS LLC	13F Company 13F	0.52%	$41,800,000 320,188 shares	—	31 Mar 2016
Apex Capital Management	13F Company 13F	0.5%	$40,524,000 310,410 shares	—	31 Mar 2016
FRANKLIN RESOURCES INC	13F Company 13F	0.46%	$36,976,000 283,231 shares	—	31 Mar 2016
DEUTSCHE BANK AG\	13F Company 13F	0.43%	$34,877,000 267,171 shares	—	31 Mar 2016
HERNDON CAPITAL MANAGEMENT LLC	13F Company 13F	0.43%	$34,369,000 263,264 shares	—	31 Mar 2016
Brandywine Global Investment Management, LLC	13F Company 13F	0.41%	$32,835,000 251,510 shares	—	31 Mar 2016
TEACHERS ADVISORS, LLC	13F Company 13F	0.41%	$32,806,000 251,291 shares	—	31 Mar 2016
Alyeska Investment Group, L.P.	13F Company 13F	0.4%	$32,436,000 248,453 shares	—	31 Mar 2016
MORGAN STANLEY	13F Company 13F	0.4%	$32,045,000 245,462 shares	—	31 Mar 2016
GOLDMAN SACHS GROUP INC	13F Company 13F	0.36%	$29,242,000 223,997 shares	—	31 Mar 2016
AMERIPRISE FINANCIAL INC	13F Company 13F	0.35%	$28,235,000 216,273 shares	—	31 Mar 2016
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.35%	$28,081,000 215,100 shares	—	31 Mar 2016
NEW YORK STATE COMMON RETIREMENT FUND	13F Company 13F	0.34%	$27,201,000 208,359 shares	—	31 Mar 2016
ARDSLEY ADVISORY PARTNERS LP	13F Company 13F	0.33%	$26,828,000 205,500 shares	—	31 Mar 2016
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.32%	$26,051,000 199,541 shares	—	31 Mar 2016
Gotham Asset Management, LLC	13F Company 13F	0.32%	$25,799,000 197,619 shares	—	31 Mar 2016
Calamos Advisors LLC	13F Company 13F	0.31%	$24,680,000 189,045 shares	—	31 Mar 2016
Tekla Capital Management LLC	13F Company 13F	0.29%	$23,380,000 179,091 shares	—	31 Mar 2016
Ninety One UK Ltd	13F Company 13F	0.28%	$22,424,000 171,769 shares	—	31 Mar 2016
COLUMBUS CIRCLE INVESTORS	13F Company 13F	0.28%	$22,186,000 169,941 shares	—	31 Mar 2016
BANK OF AMERICA CORP /DE/	13F Company 13F	0.27%	$21,608,000 165,511 shares	—	31 Mar 2016
STRS OHIO	13F Company 13F	0.26%	$21,108,000 161,690 shares	—	31 Mar 2016
EverPoint Asset Management, LLC	13F Company 13F	0.26%	$20,888,000 160,000 shares	—	31 Mar 2016

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2016

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

354

53,886,553

Rows loaded

355

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders

330

Q2 2016 holders

354

Holder diff

Investor	Q1 2016 Shares	Q2 2016 Shares	Share Diff	Share Chg %	Q1 2016 value	Q2 2016 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

Jazz Pharmaceuticals plc - Common Stock (JAZZ)

Q2 2016 13F Holders as of 30 Jun 2016

Holder history for CUSIP G50871105

Top shareholders of JAZZ - Jazz Pharmaceuticals plc - Common Stock (13F + 13D/G + 3/4/5)

PUTNAM INVESTMENTS LLC

FMR LLC

VANGUARD GROUP INC

Institutional holders as of Q2 2016

Compare Q2 2016 vs Q1 2016 Across Filers